Mukul deyoung

Mukul, our event producer, decided to put us up at an Airbnb near the palace to save costs.
Visited the Tamara de Lempika exhibition at the DeYoung museum in San Francisco this weekend.
790 years old stone doorway of Ulu Cami, Divrigi, Turkey.

•

Prospects of green financing in democratic societies

[1] Adorno TW, Frenkel-Brunswik E, Levinson, DJ, Nevitt Sanford R (1950). The Authoritarian Personality. New York: Harper & Brothers. [2] Aerts S (2013) The Consumer Does Not Exist: Overcoming the Citizen/Consumer Paradox by Shifting Focus. In Röcklinsberg H, Sandin P (Eds), The Ethics of Consumption: The Citizen, the Market and the Law, Wageningen: Academic Publishers, 172–177. https://doi.org/10.3920/978-90-8686-784-4_27 [3] Alford J, Head BW (2017) Wicked and Less Wicked Problems: A Typology and a Contingency Framework. Policy Soc 36: 397–413. https://doi.org/10.1080/14494035.2017.1361634 doi: 10.1080/14494035.2017.1361634 [4] Andina T (2018) Transgenerational Actions and Responsibility. J Crit Realism 17: 364–373. https://doi.org/10.1080/14767430.2018.1488204 doi: 10.1080/14767430.2018.1488204 [5] Andina T (2020a) The Principle of Transgenerati

•

Our team strives to match currently available targeted therapies with specific molecular alterations identified in patients, unmask molecular mechanisms of acquired resistance, and optimize novel immunotherapy strategies.

For our patients with early stage thoracic malignancies we collaborate closely with a multidisciplinary team incorporating thoracic surgeons, radiation therapists, radiologists, pulmonologists, pathologists, and biologists. In so doing, we are potentiating several treatment approaches and modalities. Given that our patients can suffer from severe symptoms our efforts also focus on ameliorating clinical outcomes by working in close connectivity with professionals across other disciplines.

Precision medicine for the treatment of advanced lung cancer is no longer an ambition. It is a guiding principle. We establish molecular determinants of disease in individual tumors and circulating cell-free DNA (cfDNA) by liquid biopsy to more effectively tailor therapies to the specificities of each patient’s individual disease.

Immune-based strategies have a role in the tre